Revision Sinus Surgery
.pdf
|
Subject Index |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
353 |
||
spontaneous CSF leak |
168, 170 |
thickened mucosa |
148 |
|
|
|
|||||||||||||
staging system |
199 |
|
|
|
|
thrombophlebitis |
314 |
|
|
|
|||||||||
– |
University of Miami |
211 |
through-cutting instrument |
65 |
|||||||||||||||
static anatomical landmark |
85 |
thunderclap headache |
219 |
|
|
||||||||||||||
stereotactic surgery |
46 |
|
|
tissue-remodelling |
32 |
|
|
|
|||||||||||
strenuous activity |
176 |
|
|
topical antifungals |
30 |
|
|
|
|||||||||||
sublabial approach |
277 |
|
|
toxic shock syndrome |
307 |
|
|
||||||||||||
sublabial incision |
278 |
|
|
341 |
tracking system |
252 |
|
|
|
284 |
|||||||||
subperiosteal orbital abscess |
transblepharoplasty approach |
||||||||||||||||||
substance P |
220 |
|
|
|
|
|
transethmoid approach |
191 |
|
||||||||||
success rate |
19 |
|
|
|
|
|
|
|
transillumination of the frontal sinus 284 |
||||||||||
suction instrumentation |
67 |
transnasal sphenoidotomy |
9 |
|
|||||||||||||||
suction irrigation |
120 |
|
|
|
transpterygoid approach |
164, 171 |
|||||||||||||
sump syndrome |
238 |
|
|
|
trauma |
|
|
|
|
|
|
|
|||||||
superantigen activity |
30 |
|
|
– |
craniofacial |
179 |
|
|
|
|
|||||||||
superior nasal septum |
8 |
|
|
– |
maxillofacial |
179 |
|
|
|
|
|||||||||
superior turbinate |
86, 110, 113 |
Trendelenburg position |
171 |
|
|||||||||||||||
– |
conservative resection |
98 |
trephination |
156, 282 |
|
|
|
||||||||||||
– |
remnant |
98 |
|
|
|
|
|
|
|
trisomy 21. see Down syndrome |
|||||||||
supraorbital |
|
|
|
|
|
|
|
|
turbinate scissors |
97 |
|
|
|
|
|||||
– |
remnant |
82 |
|
|
|
|
|
|
|
type I hypersensitivity reaction |
146 |
||||||||
supraorbital ethmoid cell |
58, 117 |
type IV frontal sinus cell |
132 |
|
|||||||||||||||
supraorbital neurovascular bundle |
283 |
|
|
|
|
|
|
|
|
||||||||||
surgical equipment |
120 |
|
63 |
U |
|
|
|
118, 131 |
|
||||||||||
surgical equipment option |
uncapping the egg |
|
|||||||||||||||||
surgical landmark |
252 |
|
|
uncinate |
|
|
|
|
|
|
|
||||||||
surgical navigation |
251 |
|
|
– |
retained |
104 |
|
|
|
|
|
||||||||
surgical performance |
|
49 |
|
uncinate process |
|
|
|
|
|
|
|||||||||
surgical planning |
253 |
|
|
|
– |
remnant |
82, 86 |
|
|
|
|
||||||||
surgical revision |
15 |
|
|
|
45 |
uncontrolled bleeding |
229 |
21 |
|||||||||||
surgical simulation training |
underling sinonasal disease |
||||||||||||||||||
surgical simulator |
48 |
|
|
|
unified airway |
21 |
|
|
|
|
|
||||||||
surgical strategy |
265 |
|
|
|
unilateral pain |
218 |
|
|
|
|
|||||||||
Surgicel |
333 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
SurgiFlo |
331 |
|
|
|
|
|
|
|
V |
|
|
|
|
|
|
|
|
||
surveillance |
149, 159, 281 |
|
vascular clip applier 68 |
|
|
|
|||||||||||||
sweat test |
27 |
|
|
|
|
|
|
|
vascularized mucosal flap 297 |
|
|||||||||
symptomatic obstruction |
13 |
vascularized periosteum |
277 |
|
|||||||||||||||
symptom score |
|
319 |
|
|
|
|
vasculitis 28, 29 |
|
|
|
|
|
|||||||
synechiae |
80, 136, 333 |
|
|
– |
necrotising granulomatous |
29 |
|||||||||||||
systemic steroids |
147 |
|
|
|
vasoconstriction 75 |
|
|
|
|
||||||||||
systemic vasculitis |
29 |
|
|
|
visual analogue scale |
200 |
|
|
|||||||||||
systemic vasodilation |
|
72 |
|
vomer 113 |
|
|
|
|
|
|
|
||||||||
T |
|
|
|
168 |
|
|
|
|
W |
|
232 |
|
|
|
|
|
|||
β2-transferrin |
|
|
|
|
washout sign |
|
|
|
|
|
|||||||||
T-cell function |
|
27 |
|
|
|
|
when to assess outcome |
317 |
|
||||||||||
target registration error |
255 |
widened frontal ostium |
157 |
|
|||||||||||||||
telescopic angle |
|
64 |
|
|
|
|
wound contracture |
113 |
|
|
|
||||||||
temporomandibular dysfunction |
221 |
|
|
|
|
|
|
|
|
||||||||||
tenacious material |
156 |
|
|
Z |
|
|
|
|
|
|
|
|
|||||||
terminal illness |
|
272 |
|
|
|
|
zero-degree endoscope |
64 |
|
|
|||||||||
tertiary amines |
|
74 |
42 |
|
|
zygomaticomaxillary fracture |
182 |
||||||||||||
therapeutic strategy |
|
|
|
|
|
|
|
|
|
|
|